Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guyana Health Review.
Press releases published on February 26, 2026
Feb. 26, 2026
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2025 Financial Results
Indeterminate
GlobeNewswire
Feb. 26, 2026
OPKO Health Reports Fourth Quarter 2025 Business Highlights and Financial Results
Indeterminate
GlobeNewswire
Feb. 26, 2026
Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance
Indeterminate
GlobeNewswire
Feb. 26, 2026
Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook
Indeterminate
GlobeNewswire
Feb. 26, 2026
Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results
Indeterminate
GlobeNewswire
Feb. 26, 2026
Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook
Indeterminate
GlobeNewswire
Feb. 26, 2026
Teknova Reports Fourth Quarter and Full Year 2025 Financial Results
Indeterminate
GlobeNewswire
Feb. 26, 2026
Xenon Reports Q4 and Full Year 2025 Financial Results and Provides Business Update
Indeterminate
GlobeNewswire
Feb. 26, 2026
Syndax Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Indeterminate
GlobeNewswire
Feb. 26, 2026
Biodesix Announces Fourth Quarter and Fiscal Year 2025 Results and Highlights
Indeterminate
GlobeNewswire
Feb. 26, 2026
Keros Therapeutics Appoints Charles Newton to its Board of Directors
Indeterminate
GlobeNewswire
Feb. 26, 2026
Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook
Indeterminate
GlobeNewswire
Feb. 26, 2026
Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results
Indeterminate
GlobeNewswire
Feb. 26, 2026
Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Indeterminate
GlobeNewswire
Feb. 26, 2026
Emergent BioSolutions Announces New $50 Million Stock Repurchase Program
Indeterminate
GlobeNewswire